NCT00575523 Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy Status COMPLETED Phase PHASE4
NCT00543946 Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese Males Status COMPLETED Phase PHASE1
NCT00510029 Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered Intravenously Status COMPLETED Phase PHASE1
NCT00507390 Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia Status WITHDRAWN Phase PHASE4
NCT00402246 CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision Status COMPLETED Phase NA
NCT00325221 Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM) Status COMPLETED Phase NA
NCT00313443 Concentrations of Amiodarone in Fat Tissue During Chronic Treatment Status COMPLETED Phase PHASE4
NCT00291174 Measuring Electrical Resistance of Different Tissues on the Outer Surface of the Heart Status TERMINATED Phase N/A
NCT00290056 Effect of Supplemental Intake of Omega-3 Polyunsaturated Fatty Acids on the Rate and Complexity of Spontaneously Occurring Ventricular and Supraventricular Arrhythmias in Patients With Implantable Cardioverter Defibrillator (ICD) - A Randomized Clinical Trial Status UNKNOWN Phase PHASE4
NCT00289289 Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT) Status COMPLETED Phase NA
NCT00282620 Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life. Status UNKNOWN Phase PHASE4